PMS Tracker: Funds slump up to 10% in August; Valcreate, Ambit drag most while select portfolios advance

Several portfolio management service (PMS) funds logged sharp declines in August, with Valcreate Investment Managers’ Lifesciences and Specialty Opportunities strategy plunging 10.19%, the steepest among tracked portfolios, according to data…

Continue ReadingPMS Tracker: Funds slump up to 10% in August; Valcreate, Ambit drag most while select portfolios advance